Journal of Biological Chemistry · 1995 · 181 citations · 19 references
Life SciencesImmunologyMolecular BiologyClinical ImmunologyImmunoregulationMolecular ImmunologyB Cell ActivationB Cell BiologyB Cell DevelopmentLymphocyte ActivationB-cell DisordersCd4 Positive T CellsCd4 T Cell ActivationCd40l SignalingDifferentiationHyper Igm SyndromesHyper-igm SyndromeMolecular Fragments
CD40 ligand (CD40L) is expressed on the surface of activated CD4+ T cells, basophils, and mast cells. Binding of C40L to its receptor, CD40, on the surface of B cells stimulates B cell proliferation, adhesion and differentiation. A preparation of soluble, recombinant CD40L (Tyr-45 to Leu-261), containing the full-length 29-kDa protein and two smaller fragments of 18 and 14 kDa, has been shown to induce differentiation of B cells derived either from normal donors or from patients with X-linked hyper-IgM syndrome (Durandy, A., Schiff, C., Bonnefoy, J.-Y., Forveille, M., Rousset, F., Mazzei, G., Milili, M., and Fischer, A. (1993) Eur. J. Immunol. 23, 2294-2299). We have now purified each of these fragments to homogeneity and show that only the 18-kDa fragment (identified as Glu-108 to Leu-261) is biologically active. When expressed in recombinant form, the 18-kDa protein exhibited full activity in B cell proliferation and differentiation assays, was able to rescue of B cells from apoptosis, and bound soluble CD40. Sucrose gradient sedimentation shows that the 18-kDa protein sediments as an apparent homotrimer, a result consistent with the proposed trimeric structure of CD40L. This demonstrates that a soluble CD40L can stimulate CD40 in a manner indistinguishable from the membrane-bound form of the protein. CD40 ligand (CD40L) is expressed on the surface of activated CD4+ T cells, basophils, and mast cells. Binding of C40L to its receptor, CD40, on the surface of B cells stimulates B cell proliferation, adhesion and differentiation. A preparation of soluble, recombinant CD40L (Tyr-45 to Leu-261), containing the full-length 29-kDa protein and two smaller fragments of 18 and 14 kDa, has been shown to induce differentiation of B cells derived either from normal donors or from patients with X-linked hyper-IgM syndrome (Durandy, A., Schiff, C., Bonnefoy, J.-Y., Forveille, M., Rousset, F., Mazzei, G., Milili, M., and Fischer, A. (1993) Eur. J. Immunol. 23, 2294-2299). We have now purified each of these fragments to homogeneity and show that only the 18-kDa fragment (identified as Glu-108 to Leu-261) is biologically active. When expressed in recombinant form, the 18-kDa protein exhibited full activity in B cell proliferation and differentiation assays, was able to rescue of B cells from apoptosis, and bound soluble CD40. Sucrose gradient sedimentation shows that the 18-kDa protein sediments as an apparent homotrimer, a result consistent with the proposed trimeric structure of CD40L. This demonstrates that a soluble CD40L can stimulate CD40 in a manner indistinguishable from the membrane-bound form of the protein.
19
Yutaka Takebe, Motoharu Seiki, Jun–ichi Fujisawa et al. · Molecular and Cellular Biology · 1988 · 1.3K citations · Full text
Mechanism of antigen-driven selection in germinal centres
Y.-J. Liu, D. Joshua, Gwyn T. Williams et al. · Nature · 1989 · 1.1K citations
Molecular and biological characterization of a murine ligand for CD40
Richard J. Armitage, William C. Fanslow, L Strockbine et al. · Nature · 1992 · 1K citations
Induction of human IgE synthesis in B cells by mast cells and basophils
Jean-François Gauchat, Sybille Henchoz, Gonzalo J. Mazzei et al. · Nature · 1993 · 652 citations
Diane Hollenbaugh, Laura S. Grosmaire, C.D. Kullas et al. · The EMBO Journal · 1992 · 513 citations · Full text